Welcome to our dedicated page for Becton, Dickinson and Company news (Ticker: $BDX), a resource for investors and traders seeking the latest updates and insights on Becton, Dickinson and Company stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Becton, Dickinson and Company's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Becton, Dickinson and Company's position in the market.
Rhea-AI Summary
BD (Becton, Dickinson and Company) responds to the FDA Safety Communication regarding plastic syringes by increasing U.S. production to meet demand. The company assures the safety and quality of its products, emphasizing its commitment to supporting the healthcare system and patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.58%
Tags
-
Rhea-AI Summary
BD (Becton, Dickinson and Company) partners with Danish health care institutions to recycle used blood collection tubes, reducing environmental impact. The innovative method involves cleaning and recycling PET plastic tubes, diverting 33 tonnes of plastic from incineration annually.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.43%
Tags
-
Rhea-AI Summary
Zeus, a leading polymer extrusion and catheter design manufacturer, appoints Padraic 'Paddy' O'Brien as the new CEO. O'Brien, currently the Worldwide President of BD Peripheral Intervention, brings a wealth of experience to lead Zeus under EQT ownership. The company aims for growth and innovation in the medical device industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.68%
Tags
Rhea-AI Summary
BD (Becton, Dickinson and Company) announces positive results from a study on automated dispensing cabinets in long-term care facilities. The study shows significant improvements in medication retrieval time, cost savings, and workflow efficiency.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.41%
Tags
-
Rhea-AI Summary
BD announces the enrollment of the first patient in the AGILITY study to assess the safety and effectiveness of the BD Vascular Covered Stent for PAD treatment. The study includes 315 patients across multiple countries and aims to address the significant unmet needs in treating PAD patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.14%
Tags
-
Rhea-AI Summary
BD (Becton, Dickinson and Company) announces the retirement of Dave Hickey, the current executive vice president and president of the Life Sciences segment effective July 1. Hickey has been with BD since 2014 and has made significant contributions, especially during the COVID-19 pandemic. BD plans to name a successor before his retirement date.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.2%
Tags
Rhea-AI Summary
BD (Becton, Dickinson and Company) partners with Camtech Health to offer at-home self-collection of samples for HPV testing in Singapore, aiming to improve cervical cancer screening rates. The program combines Camtech Health's HPV test for self-collection with BD's Onclarity™ HPV Assay, detecting 14 high-risk HPV strains. The initiative addresses barriers like lack of time, embarrassment, and fear, providing women greater access to screening. The World Health Organization's Global Strategy to Eliminate Cervical Cancer by 2030 recognizes the potential of at-home testing to reach more women and prevent cervical cancer cases caused by HPV infections.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.94%
Tags
-
Rhea-AI Summary
BD (Becton, Dickinson and Company) to present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day and Barclays 26th Annual Global Healthcare Conference. Webcasts available on investors.bd.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.33%
Tags
-
News
Rhea-AI Summary
BD (Becton, Dickinson and Company) announces the next installment of its BD Innovates series focusing on solutions for Peripheral Vascular Disease. The presentation will highlight innovations supporting BD's 2025 Strategy, emphasizing the Peripheral Vascular Disease platform within the BD Peripheral Intervention business unit.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.77%
Tags
Rhea-AI Summary
BD (Becton, Dickinson and Company) reported Q1 revenue of $4.7 billion, a 2.6% increase as reported, with 1.6% currency-neutral and 2.4% organic growth. GAAP and adjusted diluted EPS from continuing operations were $0.96 and $2.68, respectively. The company raised full-year adjusted EPS guidance and midpoint of organic revenue growth guidance for fiscal 2024. BD Medical, BD Life Sciences, and BD Interventional segments showed varying revenue changes. The company also provided an outlook for fiscal 2024, raising the lower end and midpoint of its fiscal 2024 organic revenue growth guidance range, and increasing its adjusted diluted earnings per share guidance range.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.48%
Tags
Becton, Dickinson and Company
NYSE:BDX
BDX Rankings
BDX Stock Data
67.04B
288.20M
0.31%
89.29%
1.01%
Surgical and Medical Instrument Manufacturing
Manufacturing
United States of America
FRANKLIN LAKES
About BDX
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.